FDA Oks Cardiac Insight’s wearable ECG device

The Food and Drug Administration on Thursday gave market clearance to Cardiac Insight’s wearable electrocardiogram sensor, Cardea Solo.

Advertisement

Cardea Solo is a small, lightweight, disposable sensor patients can wear under their clothes for up to one week. The device collects and analyzes ECG data to help clinicians quickly diagnose arrthymias or heart issues.

Cardiac Insights expects the device to decrease the average time for cardiac diagnosis and treatment.

More articles on supply chain:

Global pharmerging market to reach $1.4B by 2025
Price hikes likely added $8.7B to pharma’s net income for 2016, report finds
ASCO: Strategies to control drug costs hinder cancer patient care

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

  • Abbott has launched an updated version of its Oncodetect blood test, which helps clinicians determine whether cancer remains in patients…

  • Becker’s asked supply chain leaders: If you had an extra $1 million for your supply chain budget, where would it…

  • As hospitals redefine the role of supply chain leaders to focus on enterprise strategy, digital transformation and resilience, health systems…

Advertisement

Comments are closed.